(in million €) H1 2017 H2 2017 H1 2018
Recurring EBITDA (14) (10) (19)
Recurring EBIT (20) (16) (25)
of which associates 7 10 3
Total EBIT (32) (19) (18)
R&D expenditure 5 0 3
Capital expenditure 5 7 5
Capital employed, end of period 148 174 185
Capital employed, average 143 161 179
Workforce, end of period (fully consolidated) 987 1,009 1,019
Workforce, end of period (associates) 1,966 2,443 2,485